The partnership with Kanbai Tech furthers the implementation of Keya Medical’s CT-FFR physiological assessment technology in Spain. DeepVessel FFR leverages AI to provide non-invasive, accurate fractional flow reserve measurements, enhancing diagnostic precision and patient safety.
“Partnering with Kanbai Tech allows us to bring our innovative technology to more healthcare providers, thereby enhancing patient outcomes across Spain,” said Mr. Liwei Wang, CEO of Keya Medical.
By utilizing Kanbai Tech’s distribution network and expertise, the partnership aims to streamline diagnostic workflows and significantly improve patient care.
“We are excited to collaborate with Keya Medical to introduce DeepVessel FFR to Spain. This technology represents a major advancement in cardiovascular imaging, and we are proud to be at the forefront of this revolution,” stated Gianluca Galimberti, CEO of Kanbai Tech.
For more information about Kanbai Tech and their solutions visit kanbaitech.com
About DEEPVESSEL FFR
DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). The software processes coronary CTA images semi-automatically, generates a three-dimensional model of the coronary artery tree, and estimates CT FFR values. DEEPVESSEL FFR is FDA-Cleared, CE-Marked, and NMPA-Cleared.
Kanbai Tech is an international medical technology company dedicated to the development and commercialization of artificially intelligent solutions for the healthcare sector.
About Keya Medical
Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. Follow us on LinkedIn, Twitter, and Facebook.
Media Contact
contact@keyamedna.com